IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.
about
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patientsInterferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumabClinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumabDiagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaPaediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment ChoicesTh17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic ImplicationsTherapy of NMO spectrum disordersUltrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease managementMolecular pathogenesis of neuromyelitis opticaConventional and advanced imaging in neuromyelitis opticaTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesType I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisEvaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serologyCurrent concept of neuromyelitis optica (NMO) and NMO spectrum disorders.[Ultrahigh field MRI in context of neurological diseases].Magnetic resonance imaging in neuromyelitis optica.Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis OpticaPoor responses to interferon-beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.Differential diagnosis of neuromyelitis optica spectrum disorders.The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritisInterferon-β exacerbates Th17-mediated inflammatory disease.The treatment of neuromyelitis optica.Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.The frequency of anti-aquaporin-4 Ig g antibody in neuromyelitis optica and its spectrum disorders at a single tertiary referral center in malaysia.Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.CD19 as a molecular target in CNS autoimmunity.Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).New insights into neuromyelitis opticaEx vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.Janus-like effects of type I interferon in autoimmune diseases.Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporterAnti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study.Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension studyAQP4 antibody-positive Thai cases: clinical features and diagnostic problems.Microglial TIR-domain-containing adapter-inducing interferon-β (TRIF) deficiency promotes retinal ganglion cell survival and axon regeneration via nuclear factor-κB.Interferon-β1b increases Th2 response in neuromyelitis optica.Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
P2860
Q21093230-79820204-BC22-43EF-9E85-02C1ED43F6FCQ21146701-71DAB229-F660-44B6-B8EA-4A84A4857C7EQ24598109-D166DCA9-E10D-47DB-9267-E2878A4BC720Q24605493-0C014CF8-0100-42CC-86AB-E694F3D24CBCQ26748229-9649D12A-39BD-49F9-B5B0-DF2AE299A01DQ26768649-62D03C0B-5650-421E-8AF2-EFC7786DDBC7Q26779910-3B528907-FA82-40FE-962E-82F00A3A7508Q26796643-959AB794-986B-4A22-88AF-15C5B33FFC44Q27021535-0041CD7E-8B58-4469-8D77-B7525B153873Q27021822-29D52F71-886E-40C3-AEDE-F4803084BA4CQ28245749-31E6C719-63CA-4277-A9E0-EE364FB6CA27Q28251763-0A78DF69-7E98-462E-9EB1-D597D8B72907Q28728565-D58E5625-EB6F-4728-A214-60C6B17B9EF2Q30577078-68880A19-75D3-4B44-9F68-2FC93C0BA3A3Q30759627-5BB6D8EC-32B3-4B44-9212-47F1C461F85AQ30820823-1DE4055D-1D68-4121-BF5B-3D5DFB8AF9E9Q31160004-9A5A9276-006F-4823-A0E9-7DDFDB436212Q33699532-8BEC53B9-2AD3-42E0-A28A-EAEB73E8626CQ33812063-B3F5188E-4E8D-4423-89E5-AFC9EA2D855FQ34005484-844E5F1C-7745-4BFF-A0A0-AB4C8AAD7466Q34181184-7CB5A877-5193-4620-BAB9-57722BFC7BEAQ34399291-3AFDB190-0F76-4AD5-BBE3-365D66948270Q34700673-1BC9C6D8-BA77-48C7-B057-B37EBC9FE7D9Q34762744-B9471F91-A352-4567-AD31-D3AA71B5A5A5Q34785270-F184581D-DE74-4686-ABD0-BF70496F2081Q34976749-B02DEEC4-A84B-44AC-93F9-8ED66D31B02EQ35018442-609B5D20-2DB9-477C-BDAD-CF86A7EA53B2Q35052199-0A854283-60EC-461F-8245-B4164945016DQ35539641-349D8B3F-AA96-4F5D-B6ED-0256FDA019F4Q35870397-6B6C9F7B-36AA-4B0C-9C67-9B25280B0AE0Q35871686-6FD3EAC9-AA49-4D3A-8FBA-5D211EE1EF24Q35962565-7F0A057D-2A1A-4E20-BB58-EEB595E75332Q36059960-98BC6BC2-F1E6-4CC3-B5D9-79DFCC69AE4DQ36117107-C1EA78F7-68D6-4418-A3CE-C33D7FAF01F7Q36242655-1DD8897B-8FA5-4819-868B-FFE1F0CCCB0BQ36262843-0EB5AC9B-35DA-4295-B32A-EF856E95B826Q36293971-4F304EFA-0715-448D-894A-746DE3BE3468Q36317535-7AD259A7-B543-4E8C-8B4F-AC4DFAC7576FQ36396409-E4DA09C4-2EC5-4E4F-8C47-D1F3F5813377Q36484394-2371B8BA-326E-4FD1-BA94-1D539386A3DA
P2860
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@en
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@nl
type
label
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@en
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@nl
prefLabel
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@en
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@nl
P2093
P1433
P1476
IFNβ-1b may severely exacerbat ...... neuromyelitis optica spectrum.
@en
P2093
I Sugimoto
K Hashimoto
M Hasegawa
P304
P356
10.1212/WNL.0B013E3181F8832E
P407
P577
2010-09-08T00:00:00Z